Skip to main content
Caplight Logo









Gynica

Gynica

Private
Tel AvivHealthcare & Life Scienceshttps://gynica.com/

Last Round

Seed

Jun 24, 2021

Est. Valuation

$7.75M

Total Funding Raised

$1.55M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Gynica is a clinical-stage biotech company that develops non-hormonal, cannabinoid-based therapeutic solutions for endometriosis and other gynecological conditions using its proprietary IntraVag drug delivery platform.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Medical Devices

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

women's healthfemtechendometriosis treatmentcannabinoid therapeuticsdrug delivery platformmicroencapsulationnon-hormonal therapygynecological painintra-vaginal deliverybiotechnologyclinical-stage biotechdysmenorrheadyspareunia

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Gynica Comparables

Compare Gynica with similar companies based on industry and business-model similarity.

Gynica comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Calla Lily Clinical Care
81%
FimmCyte
76%
Gesynta Pharma AB
76%

Gynica Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJun 24, 2021

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 22, 2026

    Monthly visitors grew 1306% MoM, reaching 1.7K.

  • Nov 6, 2025

    Monthly visitors grew 78% MoM, from 693 to 1.2K.

Gynica Filings

Explore SEC and related filing metadata, where available.

Gynica filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Gynica's valuation, stock price, and market status.

Is Gynica a public or private company?

Gynica is a private company.

What is the current stock price of Gynica?

Gynica is a private company with no public stock price. No recent secondary market data is available.

How much is Gynica worth (valuation)?

Gynica's valuation is estimated at $7.8M based on funding round data.

Can I buy Gynica stock?

Gynica shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Gynica's last funding round?

Gynica's most recent funding round was Seed on June 24, 2021.

Who are the main investors in Gynica?

Investor information for Gynica is not publicly disclosed.

Will Gynica IPO soon?

No public IPO plans have been announced for Gynica.

How can I track Gynica secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Gynica's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersTel Aviv
Employee Range6
Year Founded2019
Last FundingJun 24, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?